Rep. Bill Posey

Maddy summaryThe HEARTS Act of 2024 requires the Department of Health and Human Services to develop educational materials about cardiomyopathy for schools, families, and health professionals within 18 months of enactment. These materials will explain signs of heart conditions that can cause sudden cardiac arrest in children and young adults, provide guidelines for AED placement in schools, and include CPR training information. The bill also authorizes research on cardiomyopathy, requires a report on existing CDC activities related to the condition, and allows grants for schools to implement AED and CPR programs. The legislation does not appropriate new funds for these activities, relying on existing resources to support its provisions.

Maddy summaryHR 10549, the Sovereign State Environmental Quality Assurance Act, would abolish the Environmental Protection Agency (EPA) 270 days after enactment, requiring the EPA Administrator to wind up operations and submit a progress report within 90 days. It redirects $4.4 billion annually (2026-2029) to state environmental departments based on population, plus $880 million yearly for Treasury oversight. The Congressional Budget Office must also conduct annual efficacy studies and reports on the Act during the same funding period. This bill directly affects all 50 states, the District of Columbia, Puerto Rico, and U.S. territories by shifting federal environmental funding and oversight authority to state-level agencies.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.

Maddy summaryHR 8075, the Improving Access to Home Dialysis Act of 2024, creates a new "staff-assisted home dialysis" program to help patients who need in-person support at home for kidney dialysis treatments. It requires Medicare to add a payment increase for providers who offer this service, where trained staff (like nurses or technicians) assist patients during their initial home dialysis setup, recovery from hospitalization, or temporary needs due to illness or caregiver unavailability. The bill also mandates patient education on this option and establishes training methods, including telehealth and group sessions, to help patients and caregivers learn home dialysis skills. It further requires studies on racial disparities in home dialysis access and the development of a patient decision tool to help choose dialysis settings. The law directly affects Medicare dialysis patients needing assistance, their care providers, and Medicare's payment structure for home dialysis services.

Maddy summaryThis bill modifies Social Security Number (SSN) requirements for claiming the Child Tax Credit and Earned Income Tax Credit. It specifies that qualifying SSNs must be issued to U.S. citizens (or under specific Social Security Act provisions) and issued before the tax return due date. The changes apply to tax years beginning after December 31, 2024, and update related tax code references to use "social security number" instead of "taxpayer identification number." These are technical adjustments to eligibility criteria, not new benefits or funding.

Maddy summaryThe SOAR Act of 2024 removes supplemental oxygen and related equipment, supplies, and services from Medicare's competitive bidding program, ensuring direct Medicare payment for these items starting in 2025. It establishes new payment rates for oxygen services, including specific rates for rural areas and liquid oxygen with annual inflation adjustments, and requires oxygen suppliers to provide specific services like initial evaluations, safety education, and 24-hour coverage. The bill also adds respiratory therapist services to Medicare coverage with a new payment add-on, requires electronic templates for documenting medical necessity for oxygen services, and establishes new beneficiary rights including the right to choose suppliers and receive timely equipment repairs. This legislation directly affects Medicare beneficiaries requiring oxygen therapy, oxygen suppliers, and respiratory therapists by changing how these services are paid for and delivered.

Maddy summaryThis bill removes a requirement for ambulatory surgical centers participating in Medicare to report the COVID-19 vaccination status of their healthcare workers. Specifically, it directs the Secretary of Health and Human Services to revise Medicare regulations (42 CFR §§ 416.300-416.330) within 45 days of enactment to eliminate this reporting mandate. The change directly affects ambulatory surgical centers that receive Medicare funding, removing a specific administrative burden related to employee vaccination data. The bill focuses solely on modifying existing reporting rules, with no new funding or program requirements.

Maddy summaryHR 6790 establishes National Institutes of Health centers to advance research, early detection, and public awareness of rare kidney diseases, with a focus on rural and underserved communities. It mandates a federal study on genetic testing barriers, treatment patterns, and public awareness for rare kidney diseases affecting disproportionately impacted populations, including barriers to insurance coverage and access to specialists. The bill also funds nephrology training programs to increase specialists serving these communities and requires experiments to delay or prevent the need for dialysis and transplants. Total funding of $7 million is authorized for fiscal years 2024-2028 to support these research, education, and early intervention efforts.

Maddy summaryThe Safe Medicine Act (HR 5575) aims to reduce U.S. dependence on foreign-manufactured generic drugs by requiring federal agencies to develop a strategy within 180 days to boost domestic production of 227 essential medicines and critical inputs identified by the FDA. It mandates that the FDA issue boxed warnings on drugs from countries with systemic contamination risks (like China or India) unless their labels already include such warnings. The bill also prevents waivers of domestic procurement preferences for these essential medicines under trade agreements. This targets medicines critical for public health emergencies, such as antibiotics and blood pressure drugs, to address supply chain vulnerabilities exposed by past contamination incidents.

Maddy summaryThe DRA of 2023 adjusts Medicare payment rates for specific durable medical equipment (DME) items that were part of the 2021 competitive bidding program but for which no supplier contracts were finalized. It directly affects DME suppliers and Medicare beneficiaries by establishing a new 2024 payment formula: 90% of the adjusted payment amount plus 10% of the unadjusted fee schedule for eligible items. The bill also extends a temporary transition rule for non-rural areas through December 31, 2024, while delaying a regulatory change until 2025. These provisions aim to stabilize payments for DME items that did not transition to standard pricing under prior rules.